<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363332">
  <stage>Registered</stage>
  <submitdate>4/12/2012</submitdate>
  <approvaldate>18/01/2013</approvaldate>
  <actrnumber>ACTRN12613000071729</actrnumber>
  <trial_identification>
    <studytitle>Saline Versus Albumin Fluid Evaulation study - Extrapolation to Paediatric Intensive Care</studytitle>
    <scientifictitle>An international, observational study of the choice of resucitation fluid used in children in intensive care.</scientifictitle>
    <utrn>U1111-1137-5682</utrn>
    <trialacronym>SAFE-EPIC</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Shock</healthcondition>
    <healthcondition>Fluid administration</healthcondition>
    <healthcondition>Resuscitation</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Observation of type, volume and rate of resuscitation fluid administration and description of unit and patient factors in infants and children receiving a fluid resuscitation on the study day. All infants and children in participating intensive care units will be studied on each of two study dates (one in December 2012, and one in July 2013).</interventions>
    <comparator>All infants and children in intensive care at 12:00 midday on the study days are included, regatrdless of whether they receive a fluid bolus.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The global prevalence of fluid resuscitation in paediatric (0 to 16 years old (inclusive)) patients in intensive care. This outcome will be assessed by clinical assessments and observations made during the study period and from data available in the medical record.</outcome>
      <timepoint>Two study days (1 in summer and 1 in winter)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>The effect of region on the use of colloids as the preferred fluid resuscitation bolus (assessed by clinical observation).</outcome>
      <timepoint>Two study days (summer and winter)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>All newborns, infants or children aged 0 to 16 years (inclusive) in a participating intensive care unit at 12:00 midday on the study days.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>16</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Age 17 years or more</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>4/12/2012</anticipatedstartdate>
    <actualstartdate>4/12/2012</actualstartdate>
    <anticipatedenddate>2/07/2013</anticipatedenddate>
    <actualenddate />
    <samplesize>2100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate>NSW,QLD,SA,WA,VIC</recruitmentstate>
    <hospital>The Children's Hospital at Westmead - Westmead</hospital>
    <countryoutsideaustralia>
      <country>United Kingdom</country>
      <state>London</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Marino Festa</primarysponsorname>
    <primarysponsoraddress>Department of Paediatric Intensive Care
The Children's Hospital at westmead
Locked Bag 4001
Westmead
NSW 2145</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other Collaborative groups</fundingtype>
      <fundingname>ANZICS Clinical Trials Group - Paediatric Study Group</fundingname>
      <fundingaddress>10 Ievers Terrace
Carlton South
VIC  AUSTRALIA  3053</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Other Collaborative groups</sponsortype>
      <sponsorname>ANZICS CTG: Paediatric Study Group</sponsorname>
      <sponsoraddress>10 Ievers Terrace                               
Carlton South                                         
VIC  AUSTRALIA  3053</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Charities/Societies/Foundations</othercollaboratortype>
      <othercollaboratorname>Critical Care and Trauma Division, The George Institute</othercollaboratorname>
      <othercollaboratoraddress>PO Box M201
Missenden Rd
NSW 2050</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Charities/Societies/Foundations</othercollaboratortype>
      <othercollaboratorname>The George institute - Division of Critical Care and Trauma</othercollaboratorname>
      <othercollaboratoraddress>PO Box M201 Missenden Rd
Sydney
NSW 2050</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Almost a decade ago, the SAFE study provided information on the effect of saline and albumin resuscitation fluids in adult patients in intensive care. Despite further studies, there remains a paucity of data on the most appropriate resuscitation fluid in infants and children in intensive care. 

The SAFE Extrapolation to Paediatric Intensive Care (SAFE-EPIC) study is an international point prevalence study of fluid resuscitation practice in paediatric patients in intensive care. The SAFE-EPIC study aims to describe the type of fluid used and the patient and intensive care unit factors associated with the use of this fluid in paediatric patients (0  16 years) in registered intensive care sites in countries throughout the world on two study dates (one in December 2012, and one in July 2013).</summary>
    <trialwebsite>REDCap database, using this link: https://redcap.thegeorgeinstitute.org</trialwebsite>
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney Children's Hospitals Network Human Research Ethics Committee</ethicname>
      <ethicaddress>Locked Bag 4001
Westmead 
NSW2145</ethicaddress>
      <ethicapprovaldate>31/08/2012</ethicapprovaldate>
      <hrec>09/CHW/53</hrec>
      <ethicsubmitdate>8/08/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Marino Festa</name>
      <address>Department of Paediatric Intensive Care
The Children's Hospital at Westmead
Locked Bag 4001
Westmead
NSW 2145</address>
      <phone>+61298451992</phone>
      <fax>+61298451993</fax>
      <email>marino.festa@health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Marino Festa</name>
      <address>Department of Paediatric Intensive Care
The Children's Hospital at Westmead
Locked Bag 4001
Westmead
NSW 2145</address>
      <phone>+61298451992</phone>
      <fax>+61298451993</fax>
      <email>marino.festa@health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Marino Festa</name>
      <address>Department of Paediatric Intensive Care
The Children's Hospital at Westmead
Locked Bag 4001
Westmead
NSW 2145</address>
      <phone>+61298451992</phone>
      <fax>+61298451993</fax>
      <email>marino.festa@health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Marino Festa</name>
      <address>Department of Paediatric Intensive Care
The Children's Hospital at Westmead
Locked Bag 4001
Westmead
NSW 2145</address>
      <phone>+61 2 98451992</phone>
      <fax>+61 2 9845 1993</fax>
      <email>marino.festa@health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>